Clinical outcomes of coronavirus disease 2019 (COVID-19) in cancer patients with prior exposure to immune checkpoint inhibitors

Cancer Commun (Lond). 2020 Aug;40(8):374-379. doi: 10.1002/cac2.12077. Epub 2020 Jul 15.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Betacoronavirus / pathogenicity*
  • Coronavirus Infections / complications
  • Coronavirus Infections / drug therapy*
  • Coronavirus Infections / immunology
  • Coronavirus Infections / virology
  • Humans
  • Immunotherapy / adverse effects*
  • Neoplasms / complications
  • Neoplasms / drug therapy*
  • Neoplasms / immunology
  • Neoplasms / virology
  • Pandemics
  • Pneumonia, Viral / complications
  • Pneumonia, Viral / drug therapy*
  • Pneumonia, Viral / immunology
  • Pneumonia, Viral / virology
  • Treatment Outcome

Supplementary concepts

  • COVID-19
  • severe acute respiratory syndrome coronavirus 2